Narjust Duma on How Gender Affects the Tolerability of Immunotherapy
Oncology (Williston Park)
.
2018 Jul 15;32(7):332-3.
Author
Narjust Duma
PMID:
30080917
No abstract available
Publication types
Interview
MeSH terms
Drug Tolerance
Humans
Immunotherapy*
Melanoma / drug therapy
Programmed Cell Death 1 Receptor / immunology*
Sex Factors
Skin Neoplasms / drug therapy
Substances
Programmed Cell Death 1 Receptor